Royal Brompton & Harefield NHS Foundation Trust: Lung Diseases trials

The registry lists 16 Lung Diseases studies with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI SoftwareRecruitingNCT05933694Not applicable
• Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot TrialCompletedNCT06016959Not applicable
• AI in PRImary Care Spirometry Pathways for Diagnosis of Lung Disease (APRIL)Active, not recruitingNCT05865249Not applicable
• Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise TrialStatus unknownNCT03050424Phase 2
• Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)CompletedNCT02286063Phase 4
• The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT02221804Not applicable
• The Role of Gastroesophageal Reflux in Scleroderma Pulmonary FibrosisStatus unknownNCT02136394
• Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
• Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary DiseaseCompletedNCT01719822Not applicable
• What is an Important Change in the Short Physical Performance Battery (SPPB)?CompletedNCT01649193
• Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary DiseaseCompletedNCT01515709
• Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?CompletedNCT01507415
• Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary DiseaseStatus unknownNCT01471587
• Minimally Invasive Endoscopy in Diffuse Lung DiseaseCompletedNCT00934778Not applicable
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
• Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1